ReviewESMO open2024
Window of opportunity trials with immune checkpoint inhibitors in triple-negative breast cancer.
A Quintana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it
ReviewESMO open2024
A Quintana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.